L-Kynurenine

From NuGOwiki

(Redirected from HMDB00684)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

L-Kynurenine
2D structure for L-Kynurenine
Chemical Name 2-amino-4-(2-aminophenyl)-4-oxo-butanoic acid
Chemical Formula C10H12N2O3
CAS Number 343-65-7
Chemical Information HMDB00684
Biochemical Taxonomy

  • Amino Acids

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways Not Available
Biofluid Location

  • Blood
  • Cerebrospinal Fluid (CSF)
  • Urine

Tissue Location

  • Central Nervous System
  • Epidermis
  • Fibroblasts
  • Intestine
  • Liver
  • Neurons
  • Placenta
  • Spleen
  • Brain

Normal Biofluid Concentrations

  • Blood: 1.35 (0.7-3.0) umol/L
  • Blood: 2.4 +/- 0.49 uM
  • Cerebrospinal Fluid (CSF): 0.052 +/- 0.0031 uM
  • Cerebrospinal Fluid (CSF): 0.054 +/- 0.007 uM
  • Urine: 2.85 +/- 1.94 umol/mmol creatinine

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • CNS Infections
  • CNS Tumors
  • Hydrocephalus
  • Intraventricular Hemorrhage

Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations

  • Cerebrospinal Fluid (CSF) (CNS Infections): 2.6 +/- 1.06 uM
  • Cerebrospinal Fluid (CSF) (CNS Tumors): 1.6 +/- 0.58 uM
  • Cerebrospinal Fluid (CSF) (Hydrocephalus): 0.18 +/- 0.040 uM
  • Cerebrospinal Fluid (CSF) (Intraventricular Hemorrhage): 0.25 +/- 0.12 uM

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
Kynurenine is a metabolite of the amino acid tryptophan used in the production of niacin. L-kynurenine is a central compound of the pathway of tryptophan metabolism pathway since it can change to the neuroprotective agent kynurenic acid or to the neurotoxic agent quinolinic acid. The break-up of these endogenous compounds' balance can be observable in many disorders. It can occur in neurodegenerative disorders, such as Parkinson's disease, Huntington's and Alzheimer's disease, in stroke, in epilepsy, in multiple sclerosis, in amyotrophic lateral sclerosis, and in mental failures, such as schizophrenia and depression.

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines

  • CNS Infections
  • CNS Tumors
  • Hydrocephalus
  • Intraventricular Hemorrhage

Other (Monogenic) Disorders

guidelines


Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines